Abstract
The high resolution structure of rhodopsin has greatly enhanced current understanding of G protein–coupled receptor (GPCR) structure in the off-state, but the activation process remains to be clarified. We investigated molecular mechanisms of δ-opioid receptor activation without a preconceived structural hypothesis. Using random mutagenesis of the entire receptor, we identified 30 activating point mutations. Three-dimensional modeling revealed an activation path originating from the third extracellular loop and propagating through tightly packed helices III, VI and VII down to a VI-VII cytoplasmic switch. N- and C-terminal determinants also influence receptor activity. Findings for this therapeutically important receptor may apply to other GPCRs that respond to diffusible ligands.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Shacham, S. et al. Modeling the 3D structure of GPCRs from sequence. Med. Res. Rev. 21, 472–483 (2001).
Howard, A.D. et al. Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol. Sci. 22, 132–140 (2001).
Palczewski, K. et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739–745 (2000).
Teller, D.C., Okada, T., Behnke, C.A., Palczewski, K. & Stenkamp, R.E. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40, 7761–7772 (2001).
Okada, T., Ernst, O.P., Palczewski, K. & Hofmann, K.P. Activation of rhodopsin: new insights from structural and biochemical studies. Trends Biochem. Sci. 26, 318–324 (2001).
Meng, E.C. & Bourne, H.R. Receptor activation: what does the rhodopsin structure tell us? Trends Pharmacol. Sci. 22, 587–593 (2001).
Borhan, B., Souto, M.L., Imai, H., Shichida, Y. & Nakanishi, K. Movement of retinal along the visual transduction path. Science 288, 2209–2212 (2000).
Henderson, R. et al. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J. Mol. Biol. 213, 899–929 (1990).
Bikker, J.A., Trumpp-Kallmeyer, S. & Humblet, C. G-protein coupled receptors: models, mutagenesis, and drug design. J. Med. Chem. 41, 2911–2927 (1998).
Ballesteros, J.A., Shi, L. & Javitch, J.A. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol. 60, 1–19 (2001).
Lu, Z.L., Saldanha, J.W. & Hulme, E.C. Seven-transmembrane receptors: crystals clarify. Trends Pharmacol. Sci. 23, 140–146 (2002).
Kieffer, B.L. Opioids: first lessons from knock-out mice. Trends Pharmacol. Sci. 20, 537–544 (1999).
Matthes, H.W.D. et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene. Nature 383, 819–823 (1996).
Pfeiffer, A., Brantl, V., Herz, A. & Emrich, M. Psychomimesis mediated by κ opiate receptors. Science 233, 774–775 (1986).
Rapaka, R.S. & Porreca, F. Development of δ opioid peptides as nonaddicting analgesics. Pharm. Res. 8, 1–8 (1991).
Filliol, D. et al. δ- and μ-opioid receptor-deficient mice exhibit opposing alterations of emotional responses. Nat. Genet. 25, 195–200 (2000).
Befort, K. et al. A single nucleotide polymorphic mutation in the human μ-opioid receptor severely impairs receptor signaling. J. Biol. Chem. 276, 3130–3137 (2001).
Befort, K., Zilliox, C., Filliol, D., Yue, S. & Kieffer, B.L. Constitutive activation of delta opioid receptor by mutations in transmembrane domain III and VII. J. Biol. Chem. 274, 18574–18581 (1999).
Li, J., Chen, C., Huang, P. & Liu-Chen, L.Y. Inverse agonist up-regulates the constitutively active D3.49(164)Q mutant of the rat μ-opioid receptor by stabilizing the structure and blocking constitutive internalization and down-regulation. Mol. Pharmacol. 60, 1064–1075 (2001).
Huang, P. et al. Functional role of a conserved motif in TM6 of the rat μ opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. Biochemistry 40, 13501–13509 (2001).
Leurs, R., Smit, M., Alewijnse, A. & Timmerman, H. Agonist-independent regulation of constitutively active G-protein-coupled receptors. Trends Biochem. Sci. 23, 418–422 (1998).
Befort, K., Tabbara, L., Kling, D., Maigret, B. & Kieffer, B.L. Role of transmembrane residues of the d-opioid receptor in ligand recognition. J. Biol. Chem. 271, 10161–10168 (1996).
Vlaeminck-Guillem, V., Ho, S.C., Rodien, P., Vassart, G. & Costagliola, S. Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol. Endocrinol. 16, 736–746 (2002).
Benya, R.V. et al. Glycosylation of the gastrin-releasing peptide receptor and its effect on expression, G protein coupling, and receptor modulatory processes. Mol. Pharmacol. 58, 1490–1501 (2000).
Ferguson, S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53, 1–24 (2001).
Ponimaskin, E.G. et al. The 5-hydroxytryptamine(4a) receptor is palmitoylated at two different sites, and acylation is critically involved in regulation of receptor constitutive activity. J. Biol. Chem. 277, 2534–2546 (2002).
Valiquette, M., Vu, H.K., Yue, S.Y., Wahlestedt, C. & Walker, P. Involvement of Trp-284, Val-296, and Val-297 of the human δ-opioid receptor in binding of δ-selective ligands. J. Biol. Chem. 271, 18789–18796 (1996).
Meng, F. et al. Creating a functional opioid alkaloid binding site in the orphanin FQ receptor through site-directed mutagenesis. Mol. Pharmacol. 53, 772–777 (1998).
Spalding, T.A. & Burstein, E.S. Constitutively active muscarinic receptors. Life Sci. 68, 2511–2516 (2001).
Huang, X.P., Williams, F.E., Peseckis, S.M. & Messer, W.S. Jr. Differential modulation of agonist potency and receptor coupling by mutations of Ser388Tyr and Thr389Pro at the junction of transmembrane domain VI and the third extracellular loop of human M(1) muscarinic acetylcholine receptors. Mol. Pharmacol. 56, 775–783 (1999).
Zhao, M.M., Gaivin, R.J. & Perez, D.M. The third extracellular loop of the β2-adrenergic receptor can modulate receptor/G protein affinity. Mol. Pharmacol. 53, 524–529 (1998).
Chaturvedi, K., Christoffers, K.H., Singh, K. & Howells, R.D. Structure and regulation of opioid receptors. Biopolymers 55, 334–346 (2000).
Claude, P.A. et al. Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists. Proc. Natl. Acad. Sci. USA 93, 5715–5719 (1996).
Kjelsberg, M.A., Cotecchia, S., Ostrowski, J., Caron, M.G. & Lefkowitz, R.J. Constitutive activation of the α 1B-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem. 267, 1430–1433 (1992).
Porter, J.E., Hwa, J. & Perez, D.M. Activation of the α1b-adrenergic receptor is initiated by disruption of an interhelical salt bridge constraint. J. Biol. Chem. 271, 28318–28323 (1996).
Pauwels, P. & Wurch, T. Review: amino acid domains involved in constitutive activation of G-protein-coupled receptors. Mol. Neurobiol. 17, 109–135 (1998).
Robinson, P.R., Cohen, G.B., Zhukovsky, E.A. & Oprian, D.D. Constitutively active mutants of rhodopsin. Neuron 9, 719–725 (1992).
Marie, J. et al. Constitutive activation of the human bradykinin B2 receptor induced by mutations in transmembrane helices III and VI. Mol. Pharmacol. 55, 92–101 (1999).
Gao, Z.G. et al. Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor. J. Biol. Chem. 277, 19056–19063 (2002).
Dhawan, B.N. et al. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev. 48, 567–592 (1996).
Kosugi, S. et al. Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum. Mol. Genet. 4, 183–188 (1995).
Prioleau, C., Visiers, I., Ebersole, B.J., Weinstein, H. & Sealfon, S.C. Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor. J. Biol. Chem. 277, 36577–36584 (2002).
Parnot, C. et al. Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay. Proc. Natl. Acad. Sci. USA 97, 7615–7620 (2000).
Ballesteros, J.A. et al. Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276, 29171–29177 (2001).
Alewijnse, A.E. et al. The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor. Mol. Pharmacol. 57, 890–898 (2000).
Li, J. et al. Constitutive activation of the μ opioid receptor by mutation of D3.49(164), but not D3.32(147): D3.49(164) is critical for stabilization of the inactive form of the receptor and for its expression. Biochemistry 40, 12039–12050 (2001).
Costa, T. & Herz, A. Antagonists with negative intrinsic activity at δ opioid receptors coupled to GTP-binding proteins. Proc. Natl. Acad. Sci. USA 86, 7321–7325 (1989).
Simonin, F. et al. The human δ opioid receptor: genomic organization, cDNA cloning, functional expression and distribution in human brain. Mol. Pharmacol. 46, 1015–1021 (1994).
Sali, A., Potterton, L., Yuan, F., van Vlijmen, H. & Karplus, M. Evaluation of comparative protein modeling by MODELLER. Proteins 23, 318–326 (1995).
Thompson, J.D., Higgins, D.G., & Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673–4680 (1994).
Visiers, I., Ballesteros, J.A. & Weinstein, H. Three-dimensional representations of G protein-coupled receptor structures and mechanisms. Methods Enzymol. 343, 329–371 (2002).
Fanelli, F., Menziani, C., Scheer, A., Cotecchia, S. & De Benedetti, P.G. Theoretical study of the electrostatically driven step of receptor-G protein recognition. Proteins 37, 145–156 (1999).
Acknowledgements
We wish to thank M. Valiquette and T. Groblewski for helpful discussions, M. Hibert for critical review of the manuscript and C. Iderne, M. Ballié and G. Recht for their help. We acknowledge support of the Human Frontier Science Program, the French Centre National de la Recherche Scientifique, the French Institut National de la Santé et de la Recherche Médicale, the Université Louis Pasteur, the Association de la Recherche pour le Cancer, the Institut UPSA de la Douleur, the Mission Interministérielle de Lutte contre la Drogue et la Toxicomanie and the US National Institutes of Health, National Institute on Drug Abuse.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Décaillot, F., Befort, K., Filliol, D. et al. Opioid receptor random mutagenesis reveals a mechanism for G protein–coupled receptor activation. Nat Struct Mol Biol 10, 629–636 (2003). https://doi.org/10.1038/nsb950
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsb950
This article is cited by
-
Computational design of G Protein-Coupled Receptor allosteric signal transductions
Nature Chemical Biology (2020)
-
Interaction and regulatory functions of μ- and δ-opioid receptors in nociceptive afferent neurons
Neuroscience Bulletin (2012)
-
Live molecular recognition: visualizing opioid receptors trafficking in vivo
Journal of Inclusion Phenomena and Macrocyclic Chemistry (2009)
-
Docking studies suggest ligand-specific δ-opioid receptor conformations
Journal of Molecular Modeling (2009)
-
Modeling the human PTC bitter-taste receptor interactions with bitter tastants
Journal of Molecular Modeling (2006)